| NUVB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NUVB shares outstanding history going back to 11/16/2020:
Also see: NUVB Market Cap History NUVB YTD Return |
As of 8/3/2026 Nuvation Bio has 351.12 million NUVB shares outstanding. Investors often track the NUVB shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NUVB share count trends over time, with 24 historical shares outstanding datapoints presented, dating back to 11/16/2020.

| NUVB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NUVB shares outstanding history going back to 11/16/2020:
Also see: NUVB Market Cap History NUVB YTD Return |
| NUVB Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
NUVB Historical Shares Outstanding: +73.95% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| NUVB Stock Price Chart |
| About Nuvation Bio Inc |
| Nuvation Bio is a clinical-stage biopharmaceutical company developing therapeutic candidates focused on treating patients with cancers. Co. is developing six wholly owned compounds that have resulted from its drug discovery and development programs, which include: NUV-422, a selective small molecule inhibitor of cyclin-dependent kinase; NUV-868, a BD2-selective oral small molecule bromodomain and extra-terminal inhibitor; NUV-569, an oral small molecule selective inhibitor of Wee1 kinase, a regulator of DNA damage repair; and a drug-drug conjugate platform, which is a therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates. We show 24 historical shares outstanding datapoints in our coverage of NUVB's shares outstanding history. Understanding the changing numbers of NUVB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NUVB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NUVB by allowing them to research NUVB shares outstanding history as well as any other stock in our coverage universe. |
| NUVB Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| NUVB Share Performance |
| Shares Outstanding Peers |
| Nuvation Bio (NUVB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NUVL Shares Outstanding History NUWE Shares Outstanding History NVAX Shares Outstanding History NVCT Shares Outstanding History NVIV Shares Outstanding History NVNO Shares Outstanding History NVO Shares Outstanding History NVOS Shares Outstanding History NVRO Shares Outstanding History NVST Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.